Makalkina L, Ikhambayeva A, Akhmadyar N, Kalieva Sh, Kuzekov A
NC JSC «Astana Medical University», Nur-Sultan, Kazakhstan.
Georgian Med News. 2020 Jul-Aug(304-305):111-116.
The study gives the results of studying the structure of consumption of systemic antimicrobial drugs in children's hospitals of the Republic of Kazakhstan for 2015-2017.; Purpose of the study - To analyze the dynamics and structure of consumption of systemic antibacterial drugs (J01) in children's hospitals.; A retrospective pharmacoepidemiological study in children's hospitals in 5 regions of the Republic of Kazakhstan, using the ATC/DDD methodology according to the WHO ATC/DDD indices with the determination of the number of DDD/100 bed-days (DBD).; The data on the consumption of systemic antibacterial drugs in children's hospitals for 2015-2017 are presented. A study of the consumption of antibacterial drugs for systemic use in children's hospitals in five regions over three years revealed the following:; - high levels of systemic antibacterial drugs consumption were characteristic of children's hospitals in Karaganda and Nur-Sultan, these same hospitals lead in the number of treated patients;; - the most positive indicators of the consumption of systemic antibacterial drugs were noted in the Pavlodar children's hospital, this was due to the opening of a hospital pharmacy department with centralized dispensing of medicines from mid-2016, which allowed a significant decrease in total consumption of systemic antibacterial drugs;; - аn analysis within the J01D group ATC over three years across five regions showed that cephalosporins (cefazolin, cefuroxime, ceftriaxone, ceftazidime) were characterized by the highest levels of consumption. Data of systemic antibacterial drugs, special attention is required with the use of ceftriaxone and ceftazidime, which increase the risk of selection of multi-resistant shatmas;; - reserve systemic antibacterial drugs indicated in the WHO model list of essential medicines for children (2019) were not used, except for the children's hospital in the city of Karaganda, where the indicators were very low (DDD 100 bed days for 2016 amounted to 0.07 DBD and 0.05 DBD in 2017).; Monitoring the consumption of systemic antibacterial drugs using the ATC/DDD methodology with the determination of the number of DDD/100 bed days (DBD) allows you to identify deficiencies in the consumption of antibiotics and evaluate the effectiveness of programs for the rational use of antibiotics. The results will be used to develop a strategy to improve the use of antibacterial agents in children's hospitals.
该研究给出了2015 - 2017年哈萨克斯坦共和国儿童医院全身用抗菌药物消费结构的研究结果。研究目的——分析儿童医院全身用抗菌药物(J01)的消费动态及结构。在哈萨克斯坦共和国5个地区的儿童医院开展一项回顾性药物流行病学研究,根据世界卫生组织ATC/DDD索引采用ATC/DDD方法,确定每100床日(DBD)的限定日剂量(DDD)数。列出了2015 - 2017年儿童医院全身用抗菌药物的消费数据。对5个地区儿童医院三年来全身用抗菌药物的消费研究显示如下情况:卡拉干达和努尔苏丹的儿童医院全身用抗菌药物消费水平较高,这些医院的治疗患者数量也领先;帕夫洛达尔儿童医院全身用抗菌药物的消费指标最为理想,这是由于自2016年年中起开设了医院药房部门,实现了药品集中调配,使得全身用抗菌药物的总消费量大幅下降;对J01D组ATC在5个地区三年间的分析表明,头孢菌素(头孢唑林、头孢呋辛、头孢曲松、头孢他啶)的消费水平最高。在全身用抗菌药物数据方面,头孢曲松和头孢他啶的使用需要特别关注,因为这会增加多重耐药菌选择的风险;除了卡拉干达市的儿童医院外,世界卫生组织儿童基本药物示范清单(2019年)中列出的储备全身用抗菌药物均未使用,卡拉干达市儿童医院的相关指标非常低(2016年每100床日的DDD为0.07 DBD,2017年为0.05 DBD)。采用ATC/DDD方法监测全身用抗菌药物的消费,确定每100床日的DDD数(DBD),有助于发现抗生素消费中的不足,并评估抗生素合理使用项目的有效性。研究结果将用于制定提高儿童医院抗菌药物使用水平的策略。